Alternatives to Monovisc If You Can't Fill Your Prescription

Monovisc is a highly effective single-injection viscosupplement for knee osteoarthritis, but it isn't always accessible. Your insurer may not cover it, your provider may not stock it, or you may be facing delays from prior authorization. Whatever the reason, there are several clinically comparable alternatives that may work just as well for your knee OA — and that might be easier to find and better covered by your plan. Here's what you need to know in 2026.

Why Monovisc Isn't Always the Only Option

Monovisc works by supplementing the hyaluronic acid (HA) naturally found in healthy knee joints. When OA degrades this fluid, the joint loses its natural lubrication and shock-absorbing properties, causing pain and stiffness. Monovisc replenishes this with a single 88 mg dose of cross-linked sodium hyaluronate, providing relief that can last up to 6 months.

Several other FDA-approved viscosupplements use the same basic mechanism. While they differ in number of injections, molecular weight, HA source, and insurance formulary status, many patients achieve comparable pain relief with alternative products. Your orthopedist or rheumatologist is best positioned to help you choose based on your specific clinical picture and insurance coverage.

1. Synvisc-One (Hylan G-F 20) — Best Coverage for Single Injection

Synvisc-One is the most widely used single-injection viscosupplement alternative to Monovisc. Like Monovisc, it is administered as a single intra-articular injection, meaning just one office visit. It is manufactured by Sanofi/Genzyme and has a very strong insurance coverage footprint — it is a preferred product with Aetna and many other commercial insurers in 2026.

Synvisc-One is derived from avian (chicken comb) sources, so patients with poultry or egg allergies should inform their doctor. It delivers 6 mL of hylan G-F 20 (a higher molecular weight cross-linked HA) versus Monovisc's 4 mL of sodium hyaluronate.

Best for: Patients whose insurance prefers single-injection HA products; patients with Aetna insurance

Caution: Avian-derived; avoid if allergic to bird proteins, eggs, or feathers

2. Durolane (Sodium Hyaluronate) — Preferred by Many Commercial Insurers

Durolane is another single-injection HA viscosupplement that is preferred over Monovisc by Aetna and several BCBS plans as of 2026. It is non-avian (bacterially fermented) and delivers 3 mL of stabilized sodium hyaluronate. Durolane does not require prior authorization with many plans that prefer it, which can significantly shorten the time to treatment compared to Monovisc.

Best for: Patients with Aetna or BCBS insurance; patients who want to avoid poultry-derived products

Note: Lower volume (3 mL) than Monovisc (4 mL); some providers feel the additional HA volume in Monovisc provides superior cushioning

3. Euflexxa (1% Sodium Hyaluronate) — Best Medicare and Commercial Coverage

Euflexxa is a three-injection series (one injection per week for 3 weeks) and one of the most widely covered viscosupplements under both Medicare and commercial insurance plans. It is non-avian (fermentation-derived) and considered a preferred product by Aetna and many BCBS plans. If coverage and cost are your primary concerns, Euflexxa may be the most accessible option even though it requires three visits instead of one.

Best for: Patients prioritizing insurance coverage and lowest out-of-pocket cost; non-avian option for patients with allergies

Drawback: Requires 3 office visits over 3 weeks vs. Monovisc's single injection

4. Orthovisc (Sodium Hyaluronate) — From the Same Manufacturer as Monovisc

Orthovisc is made by the same manufacturer as Monovisc — Anika Therapeutics — and uses the same grade of non-avian sodium hyaluronate. The key difference is that Orthovisc is administered as 3–4 weekly injections rather than a single dose. Monovisc was essentially designed to deliver the equivalent of an Orthovisc multi-injection series in a single convenient injection. If your provider prefers multi-injection protocols, Orthovisc is the closest clinical equivalent to Monovisc.

Best for: Patients whose providers are familiar with Orthovisc; those who don't mind multiple visits for familiar product

5. Corticosteroid Injections — Fastest Onset, Shorter Duration

Corticosteroid injections (e.g., triamcinolone, methylprednisolone) are a very different treatment from viscosupplements but are commonly used for knee OA pain, especially when rapid relief is needed. They work by reducing inflammation rather than lubricating the joint. Relief tends to come faster (within days) but typically lasts only 4–12 weeks — shorter than the 6 months Monovisc may provide.

Corticosteroid injections are widely available, covered by virtually all insurance plans, and can be administered by a broader range of providers. They are often used as a bridge therapy while awaiting insurance approval for Monovisc or another HA product.

How to Choose the Right Alternative

Use this quick decision guide to have a productive conversation with your doctor:

If you want a single injection and have commercial insurance: Ask about Durolane or Synvisc-One — they are often preferred and may not require prior authorization

If you have Medicare: Both Monovisc and Synvisc-One are covered under Part B; Euflexxa is also a well-covered option

If you have a bird/poultry allergy: Choose a non-avian product: Monovisc, Durolane, Euflexxa, or Orthovisc

If you need relief quickly while awaiting approval: A corticosteroid injection can provide faster, if shorter-term, pain relief

Still Want Monovisc? Here's How to Keep Trying

If your prescriber specifically recommended Monovisc and you want to pursue it, use medfinder to locate a provider near you who has it in stock. You can also read our detailed guide on how to find Monovisc in stock near you for step-by-step strategies.